RxDoctor Payments DataLook up a doctor →

Chester Whitley, MD

Pediatrics · Minneapolis, MNNPI 1588735005

Payments from drug & device makers

$1,113,317in general payments, 2019–2025

Across 248 payments — averaging $4489.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$374K
  • Amicus Therapeutics, Inc.$227K
  • AstraZeneca$138K
  • Sanofi US Services Inc.$136K
  • Sanofi$78K
  • Spark Therapeutics, Inc.$44K
  • plus $117K from 8 others
$820in research payments, 2019–2025

Across 2 payments — averaging $409.91 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Spark Therapeutics, Inc.$820

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,113,317 in reported general payments places this provider in the 95th percentile of 397 pediatrics providers in Minnesota.

See all pediatrics providers in Minnesota

Medicare billing

Part B allowed, 2024
$4,260
Medicare patients
26
Services billed
33

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other pediatrics in Minneapolis

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →